Dublin – (BUSINESS WIRE) – November 16, 2021 –
The Nordic Regulation on Biological Diversity Report added to ResearchAndMarkets.coman offer.
This report gives you the opportunity to gain a broader understanding of CBD in the Nordic countries by bringing together the individual regulatory reports of Sweden, Norway, Denmark and Finland.
Each report provides a detailed overview of the cannabis, CBD and cannabis regulatory system in each country and covers all areas of the framework including extracts, end products, import/export requirements, and medical and recreational cannabis.
Norway has a fairly strict regime when it comes to CBD and hemp – they both fall under the same regulatory framework – and in Denmark CBD is a pharmaceutical, while it is not a scheduled substance in Sweden or Finland.
The benefit of this package is that it allows a comparative analysis of these four countries, allowing you to draw similarities and differences between the systems.
Despite their close proximity to each other, each country has a completely different approach to regulation, thus if you are interested in the Scandinavian market, this report provides you with a comprehensive overview of each market.
Main topics covered:
CBD regulatory report: Norway
- Executive Summary
- prospects
- cannabis plant
- Extracts as finished products
- Final products containing CBD and extracts
- Import and export requirements
- Minor cannabis
- medical cannabis
- recreational cannabis
- Related laws
- Related bodies
CBD regulatory report: Finland
- Executive Summary
- prospects
- cannabis plant
- Extracts as finished products
- Final products containing extracts
- Import and export requirements
- Minor cannabis
- medical cannabis
- recreational cannabis
- Related laws
- Related bodies
CBD regulatory report: Denmark
- Executive Summary
- prospects
- Hemp and CBD
- Extracts as finished products
- Final products containing CBD and extracts
- Import and export requirements
- medical cannabis
- recreational cannabis
- Related laws
- Related bodies
CBD regulatory report: Sweden
- Executive Summary
- prospects
- cannabis plant
- Extracts as finished products
- Final products containing CBD and extracts
- Import and export requirements
- medical cannabis
- recreational cannabis
- Related laws
- Related bodies
mentioned companies
- Canavabi
- green party
- vinola
- Canavabi
For more information about this report visit https://www.researchandmarkets.com/r/fd3dlu
View source version on businesswire.com:https://www.businesswire.com/news/home/20211116005629/ar/
Call: ResearchAndMarkets.com
Laura Wood, Senior Director of Press
For EST office hours, call 1-917-300-0470
For US/CAN, toll-free, call 1-800-526-8630
For GMT office hours, call +353-1-416-8900
Keyword: Finland, Europe, Sweden, Denmark, Norway
Industry keyword: alternative medicine for health
Source: Research and Markets
Copyright Business Wire 2021.
Published: 11/16/2021 04:29 AM / Disc: 11/16/2021 04:29 AM
Copyright Business Wire 2021.
